| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
67,657.13 | 51,587.56 | 31,522.78 | 30,729.75 | 69,962.71 |
| Cost of Revenue
|
-34,422.91 | -27,050.68 | -19,715.13 | -16,550.06 | -15,854.91 |
|
Gross Profit
|
33,234.21 | 24,536.88 | 11,807.64 | 14,179.69 | 54,107.80 |
| Selling, General and Administrative Expenses
|
-12,999.19 | -8,913.15 | -6,933.13 | -7,311.50 | -7,346.44 |
|
Exploration Expenses
|
-- | -- | -- | 0 | -9.55 |
|
Operating Income/Expenses
|
-12,999.19 | -8,913.15 | -6,933.13 | -7,311.50 | -7,355.98 |
|
Total Operating Profit/Loss
|
20,235.02 | 15,623.72 | 4,874.51 | 6,868.20 | 46,751.82 |
| Total Net Finance Income/Expense
|
-2,184.74 | -435.79 | 446.88 | 1,592.86 | 402.10 |
| Net Investment Income
|
-2,295.57 | 5,500.49 | -391.15 | 3,130.06 | 236.08 |
| Irregular Income/Expenses
|
-19,564.02 | -26,141.11 | -1,450.08 | -1,449.87 | 221.64 |
|
Other Income/Expense, Non-Operating
|
-142.34 | 16.56 | 76.73 | 4.36 | -99.47 |
|
Non-Operating Income/Expenses, Total
|
-24,186.66 | -21,059.86 | -1,317.62 | 3,277.40 | 760.35 |
|
Pretax Income
|
-3,951.64 | -5,436.13 | 3,556.89 | 10,145.60 | 47,512.17 |
|
Provision for Income Tax
|
448.18 | -362.73 | -1,629.09 | -3,200.45 | -12,157.49 |
|
Net Income from Continuing Operations
|
-3,503.46 | -5,798.86 | 1,927.80 | 6,945.15 | 35,354.68 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-3,503.46 | -5,798.86 | 1,927.80 | 6,945.15 | 35,354.68 |
|
Net Income after Non-Controlling/Minority Interests
|
-3,503.46 | -5,798.86 | 1,927.80 | 6,945.15 | 35,354.68 |
|
Net Income Available to Common Stockholders
|
-3,503.46 | -5,798.86 | 1,927.80 | 6,945.15 | 35,354.68 |
|
Diluted Net Income Available to Common Stockholders
|
-3,503.46 | -5,798.86 | 1,927.80 | 6,945.15 | 35,354.68 |
|
Common Dividend per Share
|
0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Basic EPS
|
-0.24 | -0.25 | 0.09 | 0.31 | 1.52 |
| Diluted EPS
|
-0.24 | -0.25 | 0.09 | 0.31 | 1.51 |
|
Basic Weighted Average Shares Outstanding
|
27,136.28 | 23,020.67 | 21,930.28 | 22,496.77 | 23,319.63 |
|
Diluted Weighted Average Shares Outstanding
|
27,136.28 | 23,020.67 | 21,930.28 | 22,511.65 | 23,406.19 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,766.90 | -5,000.34 | 3,110.02 | 8,552.74 | 47,110.07 |
|
EBITDA
|
9,532.36 | 7,169.98 | 13,295.14 | 16,237.82 | 53,548.58 |
|
Normalized EBITDA
|
37,145.27 | 30,743.98 | 17,578 | 18,827.51 | 52,885.20 |
|
Normalized Income
|
18,827.71 | 16,575.01 | 5,783.16 | 6,492 | 35,773.89 |
|
Total Unusual Items
|
25,187.88 | 26,322.21 | 4,535.72 | -661.92 | 563.31 |
12/31/2022 - 11/15/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade